Single-cell-led drug repurposing for Alzheimer’s disease
In our new study genomics meets single-cell transcriptomics to unveil drug repurposing candidates for Alzheimer’s disease.
We developed a computational framework based on network analysis to integrate different data types describing the disease biology and establish a connection between disease pathways and existing drugs that could be further evaluated in experimental settings for their potential as Alzheimer’s disease therapeutics.
View on Scientific Reports website
